187 related articles for article (PubMed ID: 35978822)
21. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma.
Zhang X; Wu Z; Ma K
BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of the immune microenvironment associated with RRM2 expression and its application to PD-L1/PD-1 inhibitors in lung adenocarcinoma.
Lee SK; Hwang Y; Han JH; Haam S; Lee HW; Koh YW
Am J Cancer Res; 2023; 13(11):5443-5454. PubMed ID: 38058821
[TBL] [Abstract][Full Text] [Related]
23. SPAG5 Expression Predicts Poor Prognosis and is Associated With Adverse Immune Infiltration in Lung Adenocarcinomas.
Xiao G; Xu X; Chen Z; Zeng J; Xie J
Clin Med Insights Oncol; 2023; 17():11795549231199915. PubMed ID: 37744424
[TBL] [Abstract][Full Text] [Related]
24. Comparative expression analysis of PD-1, PD-L1, and CD8A in lung adenocarcinoma.
Ma K; Qiao Y; Wang H; Wang S
Ann Transl Med; 2020 Nov; 8(22):1478. PubMed ID: 33313223
[TBL] [Abstract][Full Text] [Related]
25. Serum exosomal miR-16-5p functions as a tumor inhibitor and a new biomarker for PD-L1 inhibitor-dependent immunotherapy in lung adenocarcinoma by regulating PD-L1 expression.
Chen HL; Luo YP; Lin MW; Peng XX; Liu ML; Wang YC; Li SJ; Yang DH; Yang ZX
Cancer Med; 2022 Jul; 11(13):2627-2643. PubMed ID: 35347894
[TBL] [Abstract][Full Text] [Related]
26. Screening and validation of plasma cell-derived, purinergic, and calcium signalling-related genetic signature to predict prognosis and PD-L1/PD-1 blockade responses in lung adenocarcinoma.
Huang J; Fan X; Hu B; Chen L
J Cancer Res Clin Oncol; 2023 Nov; 149(14):12931-12945. PubMed ID: 37468608
[TBL] [Abstract][Full Text] [Related]
27. Decreased zinc-fingers and homeoboxes family expression was associated with unfavorable outcomes and immune infiltration in lung adenocarcinoma.
Tao D; Tan J; Zhang N; Yang D; Jiang Y; Zhou W; Wang Y; Wu Y
Transl Cancer Res; 2023 Jun; 12(6):1422-1440. PubMed ID: 37434685
[TBL] [Abstract][Full Text] [Related]
28. Qingfei Jiedu decoction inhibits PD-L1 expression in lung adenocarcinoma based on network pharmacology analysis, molecular docking and experimental verification.
Pan J; Yang H; Zhu L; Lou Y; Jin B
Front Pharmacol; 2022; 13():897966. PubMed ID: 36091822
[No Abstract] [Full Text] [Related]
29. Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.
Wei Q; Miao T; Zhang P; Jiang B; Yan H
Front Genet; 2022; 13():984575. PubMed ID: 36159963
[No Abstract] [Full Text] [Related]
30. CD44, a marker of cancer stem cells, is positively correlated with PD-L1 expression and immune cells infiltration in lung adenocarcinoma.
Zhang C; Wang H; Wang X; Zhao C; Wang H
Cancer Cell Int; 2020 Dec; 20(1):583. PubMed ID: 33372595
[TBL] [Abstract][Full Text] [Related]
31. AIM2 upregulation promotes metastatic progression and PD-L1 expression in lung adenocarcinoma.
Zheng JQ; Lin CH; Lee HH; Chang WM; Li LJ; Su CY; Lee KY; Chiu HW; Lin YF
Cancer Sci; 2023 Jan; 114(1):306-320. PubMed ID: 36104978
[TBL] [Abstract][Full Text] [Related]
32. Long Non-Coding RNA-TMPO-AS1 as ceRNA Binding to let-7c-5p Upregulates STRIP2 Expression and Predicts Poor Prognosis in Lung Adenocarcinoma.
Wang J; Yuan Y; Tang L; Zhai H; Zhang D; Duan L; Jiang X; Li C
Front Oncol; 2022; 12():921200. PubMed ID: 35774125
[TBL] [Abstract][Full Text] [Related]
33. DFNA5 regulates immune cells infiltration and exhaustion.
Hu J; Pei W; Jiang M; Huang Y; Dong F; Jiang Z; Xu Y; Li Z
Cancer Cell Int; 2022 Mar; 22(1):107. PubMed ID: 35248047
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of phosphodiesterase 4D decreases the malignant properties of DLD-1 colorectal cancer cells by repressing the AKT/mTOR/Myc signaling pathway.
Kim DU; Nam J; Cha MD; Kim SW
Oncol Lett; 2019 Mar; 17(3):3589-3598. PubMed ID: 30867802
[TBL] [Abstract][Full Text] [Related]
35. Association of long noncoding RNA MALAT1 with the radiosensitivity of lung adenocarcinoma cells via the miR-140/PD-L1 axis.
Li S; Xie Y; Zhou W; Zhou Q; Tao D; Yang H; Mao K; Li S; Lei J; Wu Y; Wang Y
Heliyon; 2023 Jun; 9(6):e16868. PubMed ID: 37332979
[TBL] [Abstract][Full Text] [Related]
36. GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma.
Song S; Deng X; Jiang S; Tian C; Han J; Chai J; Li N; Yan Y; Luo Z
J Clin Lab Anal; 2022 Nov; 36(11):e24662. PubMed ID: 36181310
[TBL] [Abstract][Full Text] [Related]
37.
Xu T; Xu S; Yao Y; Chen X; Zhang Q; Zhao X; Wang X; Zhu J; Liu N; Zhang J; Lin Y; Zou J
J Thorac Dis; 2022 Feb; 14(2):515-535. PubMed ID: 35280459
[TBL] [Abstract][Full Text] [Related]
38. The downregulation of fibrinogen-like protein 1 inhibits the proliferation of lung adenocarcinoma via regulating
Tang XY; Xiong YL; Shi AP; Sun Y; Han Q; Lv Y; Shi XG; Frattini M; Malhotra J; Zheng KF; Liu YJ; Jiang T; Ma N; Zhao JB
Transl Lung Cancer Res; 2022 Mar; 11(3):404-419. PubMed ID: 35399566
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
[TBL] [Abstract][Full Text] [Related]
40. High expression of glycolysis-related
Yu H; Yu Z; Qin C; Bian T; Shi M
J Thorac Dis; 2022 Sep; 14(9):3488-3499. PubMed ID: 36245582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
